Dr. Irene Ghobrial, MD
Claim this profileDana Farber Cancer Institute
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
8 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Irene Ghobrial, MD is currently running
CAR T-Cell Therapy
for Multiple Myeloma
The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering myeloma. The names of the treatment interventions used in this study are: * Cilta-cel (or chimeric antigen receptor T cells) * Cyclophosphamide (a lymphodepleting chemotherapy) * Fludarabine (a lymphodepleting chemotherapy)
Recruiting1 award Phase 28 criteria
Teclistamab vs Lenalidomide + Dexamethasone
for Multiple Myeloma
This trial is testing a new drug called Teclistamab against a combination of two existing drugs, Lenalidomide and Dexamethasone, in people with high-risk smoldering multiple myeloma. The goal is to see which treatment is more effective in preventing the progression to active multiple myeloma. Teclistamab helps the immune system target cancer cells, while Lenalidomide and Dexamethasone work together to boost the immune response and reduce inflammation.
Recruiting1 award Phase 29 criteria
More about Irene Ghobrial, MD
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Irene Ghobrial, MD has experience with
- Dexamethasone
- Lenalidomide
- Daratumumab
- Ciltacabtagene Autoleucel
- Cyclophosphamide
- Fludarabine Phosphate
Breakdown of trials Irene Ghobrial, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Monoclonal Gammopathy
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irene Ghobrial, MD specialize in?
Irene Ghobrial, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Irene Ghobrial, MD currently recruiting for clinical trials?
Yes, Irene Ghobrial, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Irene Ghobrial, MD has studied deeply?
Yes, Irene Ghobrial, MD has studied treatments such as Dexamethasone, Lenalidomide, Daratumumab.
What is the best way to schedule an appointment with Irene Ghobrial, MD?
Apply for one of the trials that Irene Ghobrial, MD is conducting.
What is the office address of Irene Ghobrial, MD?
The office of Irene Ghobrial, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.